Deciphering the role of PGC-1α in neurological disorders: from mitochondrial dysfunction to synaptic failureJessica D.Panes,Aline Wendt,Oscar Ramirez-Molina,Patricio A.Castro,Jorge Fuentealba237-245
Dying by fire: noncanonical functions of autophagy proteins in neuroinflammation and neurodegenerationAlexis D.Rickman,Addison Hilyard,Bradlee L.Heckmann246-250
Transcranial magnetic stimulation in animal models of neurodegenerationMohammad Uzair,Turki Abualait,Muhammad Arshad,Woo-Kyoung Yoo,Ali Mir,Reem Fahd Bunyan,Shahid Bashir251-265
SYNGR4 and PLEKHB1 deregulation in motor neurons of amyotrophic lateral sclerosis models: potential contributions to pathobiologyRita F.Marques,Kent E.Duncan266-270
Challenges in developing therapeutic strategies for mild neonatal encephalopathyAlice Mc,Douall,Guido Wassink,Laura Bennet,Alistair J.Gunn,Joanne O.Davidson277-282
Delving into the recent advancements of spinal cord injury treatment: a review of recent progressJoseph A.Flack,Krishna Deo Sharma,Jennifer Yanhua Xie283-291
Hyperglycemia in acute ischemic stroke: physiopathological and therapeutic complexityFederica Ferrari,Antonio Moretti,Roberto Federico Villa292-299
Inserting new synaptic connections into damaged neural circuits: towards synapse therapy?Ithai Rabinowitch300-301
Celeboxib-mediated neuroprotection in focal cerebral ischemia: an interplay between unfolded protein response and inflammationMaría Santos-Galdiano,Diego Pérez-Rodríguez,Arsenio Fernández-López302-303